Medium & long-chain acylcarnitine’s relation to lipid metabolism as potential predictors for diabetic cardiomyopathy: a metabolomic study

BACKGROUND: Acylcarnitine is an intermediate product of fatty acid oxidation. It is reported to be closely associated with the occurrence of diabetic cardiomyopathy (DCM). However, the mechanism of acylcarnitine affecting myocardial disorders is yet to be explored. This current research explores the...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Dan-meng, An, Zhen-ni, Ge, Ming-hao, Wei, Dong-zhuo, Jiang, Ding-wen, Xing, Xue-jiao, Shen, Xiao-lei, Liu, Chang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8562007/
https://www.ncbi.nlm.nih.gov/pubmed/34727932
http://dx.doi.org/10.1186/s12944-021-01576-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8562007/
https://www.ncbi.nlm.nih.gov/pubmed/34727932
http://dx.doi.org/10.1186/s12944-021-01576-9

Ejemplares similares